Metastatic pancreatic adenocarcinoma Trials in Atlanta, United States
Conditions / Metastatic pancreatic adenocarcinoma / Atlanta, United States
Metastatic pancreatic adenocarcinoma is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02231723 | A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer | COMPLETED | PHASE1 |
| NCT01233375 | Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma | COMPLETED | PHASE2 |
| NCT03368963 | TAS102 in Combination With NAL-IRI in Advanced GI Cancers | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT04524702 | Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer | COMPLETED | PHASE2 |
| NCT04191421 | Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer | COMPLETED | PHASE1/PHASE2 |
| NCT03337087 | Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT03611556 | MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. | COMPLETED | PHASE1/PHASE2 |
| NCT03095781 | Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Cancer | COMPLETED | PHASE1 |
| NCT06998940 | Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations | RECRUITING | PHASE3 |
| NCT03910387 | Telotristat Ethyl to Promote Weight Stability in Patients With Advanced Stage Pancreatic Cancer | COMPLETED | PHASE2 |